Display of Streptococcus iniae α-Enolase on the Surface of Virus-Like Particles (VLPs) of Nervous Necrosis Virus (NNV) Using SpyTag/SpyCatcher

被引:4
作者
Yang, Jeong In [1 ]
Kim, Ki Hong [1 ]
机构
[1] Pukyong Natl Univ, Dept Aquat Life Med, Busan 48513, South Korea
关键词
Nervous necrosis virus; Virus-like particle; SpyTag; SpyCatcher; Surface display; Antigen delivery; DNA VACCINE; GLYCOPROTEIN; IMMUNIZATION; EFFICACY; FISH;
D O I
10.1007/s10126-022-10166-4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Virus-like particle (VLP)-based vaccines are promising candidates for overcoming the safety problems of live vaccines and weak immunogenicity of subunit vaccines. VLPs can be used as a platform for the development of combined vaccines by expressing foreign antigens, and foreign antigens can be displayed on the surface of VLPs by conjugation. In the present study, to use nervous necrosis virus (NNV) VLPs as a delivery tool for Streptococcus iniae alpha-enolase by displaying on the VLP's surface, the split-intein (SpyTag/SpyCatcher) conjugation system was used. NNV capsid protein fused to SpyTag (Capsid-SpyTag) and S. iniae alpha-enolase fused to SpyCatcher (alpha-enolase-SpyCatcher) were recombinantly produced, then mixed in various ratios. A ratio of Capsid-SpyTag to alpha-enolase-SpyCatcher of 1 to 1.5 showed the highest coupling efficiency corresponding to 83-92% of coupled capsid protein dimer and 32-52% of coupled capsid protein monomer. In TEM observation, VLP of Capsid-SpyTag had a regular shape and size of about 40 nm, while VLP fused with alpha-enolase-SpyCatcher showed an irregular shape and size of about 40-50 nm in diameter. In preliminary immunization experiments, olive flounder (Paralichthys olivaceus) and zebrafish (Danio rerio) immunized with VLP fused with alpha-enolase-SpyCatcher showed the lowest cumulative mortality against S. iniae infection.
引用
收藏
页码:1066 / 1072
页数:7
相关论文
共 35 条
  • [1] Progress, challenges and opportunities in fish vaccine development
    Adams, Alexandra
    [J]. FISH & SHELLFISH IMMUNOLOGY, 2019, 90 : 210 - 214
  • [2] Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization
    Brune, Karl D.
    Leneghan, Darren B.
    Brian, Iona J.
    Ishizuka, Andrew S.
    Bachmann, Martin F.
    Draper, Simon J.
    Biswas, Sumi
    Howarth, Mark
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [3] Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease
    Castilow, Elaine M.
    Olson, Matthew R.
    Varga, Steven M.
    [J]. IMMUNOLOGIC RESEARCH, 2007, 39 (1-3) : 225 - 239
  • [4] Determinants of autoantibody induction by conjugated papillomavirus virus-like particles
    Chackerian, B
    Lenz, P
    Lowy, DR
    Schiller, JT
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (11) : 6120 - 6126
  • [5] Oral immunization with cell-free self-assembly virus-like particles against orange-spotted grouper nervous necrosis virus in grouper larvae, Epinephelus coioides
    Chien, Ming-Hui
    Wu, Shaw-Yun
    Lin, Cheng-Hui
    [J]. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2018, 197 : 69 - 75
  • [6] Virus-like particles: The new frontier of vaccines for animal viral infections
    Crisci, Elisa
    Barcena, Juan
    Montoya, Maria
    [J]. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2012, 148 (3-4) : 211 - 225
  • [7] Virus-like particle vaccines: immunology and formulation for clinical translation
    Donaldson, Braeden
    Lateef, Zabeen
    Walker, Greg F.
    Young, Sarah L.
    Ward, Vernon K.
    [J]. EXPERT REVIEW OF VACCINES, 2018, 17 (09) : 833 - 849
  • [8] FAO, 2018, STATE WORLD FISHERIE
  • [9] Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
    Florencia Delgado, Maria
    Coviello, Silvina
    Clara Monsalvo, A.
    Melendi, Guillermina A.
    Zea Hernandez, Johanna
    Batalle, Juan P.
    Diaz, Leandro
    Trento, Alfonsina
    Chang, Herng-Yu
    Mitzner, Wayne
    Ravetch, Jeffrey
    Melero, Jose A.
    Irusta, Pablo M.
    Polack, Fernando P.
    [J]. NATURE MEDICINE, 2009, 15 (01) : 34 - 41
  • [10] Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus
    Garg, Himanshu
    Mehmetoglu-Gurbuz, Tugba
    Joshi, Anjali
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)